Publications by authors named "Thomas Mourez"

Claim this Profile
I
In vitro replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental viruses.
Alice Moisan, Fabienne Tombette, Manon Vautrin, Elodie Alessandri-Gradt, Thomas Mourez

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive meningoencephalitis as the first manifestation of hepatitis A.
Maxime Guillaume, Lina Mouna, François Coustillères, Véronique Lemée, Anne-Marie Roque-Afonso, Thomas Mourez

J Viral Hepat· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
Anne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, Pantxika Bellecave, Laura Le Guen, Thomas Mourez

J Antimicrob Chemother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors.
Thomas Mourez, Véronique Lemée, Valérie Delbos, Constance Delaugerre, Elodie Alessandri-Gradt

EBioMedicine· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir.
Elodie Alessandri-Gradt, Charlotte Charpentier, Marie Leoz, Thomas Mourez, Diane Descamps

J Antimicrob Chemother· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mumps virus: a comprehensive review.
Thomas Mourez, Julia Dina

Virologie (Montrouge)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mumps virus: a comprehensive review].
Thomas Mourez, Julia Dina

Virologie (Montrouge)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of numerous HIV-1/MO recombinants in France.
Fabienne De Oliveira, Pierre Cappy, Véronique Lemée, Alice Moisan, Charlotte Pronier, Thomas Mourez

AIDS· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.
Stéphanie Raymond, Florence Nicot, Coralie Pallier, Pantxika Bellecave, Anne Maillard, Thomas Mourez

Clin Infect Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.
Thomas Mourez, Amandine Decroos, Odile Goria, Hélène Montialoux, Fabienne De Oliveira

J Med Virol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping.
Virginie Morel, Elodie Martin, Catherine François, François Helle, Justine Faucher, Thomas Mourez

J Clin Microbiol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon.
Fabienne De Oliveira, Thomas Mourez, Aurélia Vessiere, Paul-Alain Ngoupo, Elodie Alessandri-Gradt

Retrovirology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First report of transmission of a highly resistant strain of HIV-1 group O.
Guillemette Unal, Thomas Mourez, Marie Leoz, Elodie Alessandri-Gradt, Hélène Le Guillou-Guillemette

AIDS· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants.
Marie Gueudin, Adeline Baron, Elodie Alessandri-Gradt, Véronique Lemée, Thomas Mourez

J Acquir Immune Defic Syndr· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First evidence of transmission of an HIV-1 M/O intergroup recombinant virus.
Paul Alain Ngoupo, Serge Alain Sadeuh-Mba, Fabienne De Oliveira, Valérie Ngono, Laure Ngono, Thomas Mourez

AIDS· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants.
Thomas Mourez, Constance Delaugerre, Muriel Vray, Véronique Lemée, François Simon

J Clin Virol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.
Sylvie Larrat, Sophie Vallet, Sandra David-Tchouda, Alban Caporossi, Jennifer Margier, Thomas Mourez

J Clin Microbiol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.
Jeremie Leporrier, Manuel Etienne, Claire Chapuzet, Gilles Peytavin, Stephane Bord, Thomas Mourez

J Clin Virol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir.
Charlotte Charpentier, Mélanie Bertine, Benoit Visseaux, Juliette Leleu, Lucile Larrouy, Thomas Mourez

AIDS· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithm-based prediction of HIV-1 subtype D coreceptor use.
Julia Dina, Stephanie Raymond, Anne Maillard, Helene Le Guillou-Guillemette, Audrey Rodalec, Thomas Mourez

J Clin Microbiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-M variants of human immunodeficiency virus type 1.
Thomas Mourez, François Simon, Jean-Christophe Plantier

Clin Microbiol Rev· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Proposal of HIV, HBV and HCV targeted screening: short period feasibility study in a free-access outpatient medical structure].
Caroline Aparicio, Thomas Mourez, Guy Simoneau, Jean-Dominique Magnier, Bertrand Galichon

Presse Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells.
Thomas Mourez, Mariana Mesel-Lemoine, Chantal Combredet, Valérie Najburg, Nadège Cayet

Virology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.
Constance Delaugerre, Blandine Denis, Gilles Peytavin, Pierre Palmer, Thomas Mourez

J Clin Microbiol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.
Grégory Caignard, Anastassia V Komarova, Mehdi Bouraï, Thomas Mourez, Yves Jacob

PLoS Pathog· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis